vs

Side-by-side financial comparison of RXO, Inc. (RXO) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.

RXO, Inc. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× SELECT MEDICAL HOLDINGS CORP). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 1.4% vs -3.1%, a 4.6% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs -11.9%). SELECT MEDICAL HOLDINGS CORP produced more free cash flow last quarter ($5.2M vs $-9.0M). Over the past eight quarters, RXO, Inc.'s revenue compounded faster (26.8% CAGR vs 2.8%).

RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.

Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.

RXO vs SEM — Head-to-Head

Bigger by revenue
RXO
RXO
1.1× larger
RXO
$1.5B
$1.4B
SEM
Growing faster (revenue YoY)
SEM
SEM
+18.3% gap
SEM
6.4%
-11.9%
RXO
Higher net margin
SEM
SEM
4.6% more per $
SEM
1.4%
-3.1%
RXO
More free cash flow
SEM
SEM
$14.2M more FCF
SEM
$5.2M
$-9.0M
RXO
Faster 2-yr revenue CAGR
RXO
RXO
Annualised
RXO
26.8%
2.8%
SEM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RXO
RXO
SEM
SEM
Revenue
$1.5B
$1.4B
Net Profit
$-46.0M
$20.2M
Gross Margin
Operating Margin
-2.9%
4.6%
Net Margin
-3.1%
1.4%
Revenue YoY
-11.9%
6.4%
Net Profit YoY
-84.0%
225.7%
EPS (diluted)
$-0.28
$0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RXO
RXO
SEM
SEM
Q4 25
$1.5B
$1.4B
Q3 25
$1.4B
$1.4B
Q2 25
$1.4B
$1.3B
Q1 25
$1.4B
$1.4B
Q4 24
$1.7B
$1.3B
Q3 24
$1.0B
$1.3B
Q2 24
$930.0M
$1.3B
Q1 24
$913.0M
$1.3B
Net Profit
RXO
RXO
SEM
SEM
Q4 25
$-46.0M
$20.2M
Q3 25
$-14.0M
$28.8M
Q2 25
$-9.0M
$40.6M
Q1 25
$-31.0M
$56.7M
Q4 24
$-25.0M
$-16.1M
Q3 24
$-243.0M
$55.6M
Q2 24
$-7.0M
$77.6M
Q1 24
$-15.0M
$96.9M
Operating Margin
RXO
RXO
SEM
SEM
Q4 25
-2.9%
4.6%
Q3 25
-0.5%
5.4%
Q2 25
6.5%
Q1 25
-2.1%
8.3%
Q4 24
-1.4%
1.6%
Q3 24
-1.9%
4.3%
Q2 24
5.8%
Q1 24
-1.3%
9.0%
Net Margin
RXO
RXO
SEM
SEM
Q4 25
-3.1%
1.4%
Q3 25
-1.0%
2.1%
Q2 25
-0.6%
3.0%
Q1 25
-2.2%
4.2%
Q4 24
-1.5%
-1.2%
Q3 24
-23.4%
4.4%
Q2 24
-0.8%
6.1%
Q1 24
-1.6%
7.3%
EPS (diluted)
RXO
RXO
SEM
SEM
Q4 25
$-0.28
$0.17
Q3 25
$-0.08
$0.23
Q2 25
$-0.05
$0.32
Q1 25
$-0.18
$0.44
Q4 24
$-0.17
$-0.12
Q3 24
$-1.81
$0.43
Q2 24
$-0.06
$0.60
Q1 24
$-0.13
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RXO
RXO
SEM
SEM
Cash + ST InvestmentsLiquidity on hand
$17.0M
$26.5M
Total DebtLower is stronger
$387.0M
$1.8B
Stockholders' EquityBook value
$1.5B
$1.7B
Total Assets
$3.3B
$5.9B
Debt / EquityLower = less leverage
0.25×
1.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RXO
RXO
SEM
SEM
Q4 25
$17.0M
$26.5M
Q3 25
$25.0M
$60.1M
Q2 25
$18.0M
$52.3M
Q1 25
$16.0M
$53.2M
Q4 24
$35.0M
$59.7M
Q3 24
$55.0M
$191.5M
Q2 24
$7.0M
$111.2M
Q1 24
$7.0M
$92.6M
Total Debt
RXO
RXO
SEM
SEM
Q4 25
$387.0M
$1.8B
Q3 25
$387.0M
$1.7B
Q2 25
$387.0M
$1.8B
Q1 25
$387.0M
$1.8B
Q4 24
$351.0M
$1.7B
Q3 24
$352.0M
$3.1B
Q2 24
$370.0M
$3.6B
Q1 24
$351.0M
$3.8B
Stockholders' Equity
RXO
RXO
SEM
SEM
Q4 25
$1.5B
$1.7B
Q3 25
$1.6B
$1.7B
Q2 25
$1.6B
$1.7B
Q1 25
$1.6B
$1.7B
Q4 24
$1.6B
$1.7B
Q3 24
$1.7B
$1.9B
Q2 24
$579.0M
$1.4B
Q1 24
$582.0M
$1.4B
Total Assets
RXO
RXO
SEM
SEM
Q4 25
$3.3B
$5.9B
Q3 25
$3.2B
$5.7B
Q2 25
$3.2B
$5.7B
Q1 25
$3.3B
$5.7B
Q4 24
$3.4B
$5.6B
Q3 24
$3.4B
$8.0B
Q2 24
$1.8B
$7.9B
Q1 24
$1.8B
$7.9B
Debt / Equity
RXO
RXO
SEM
SEM
Q4 25
0.25×
1.06×
Q3 25
0.24×
1.03×
Q2 25
0.24×
1.10×
Q1 25
0.24×
1.03×
Q4 24
0.22×
1.01×
Q3 24
0.21×
1.62×
Q2 24
0.64×
2.54×
Q1 24
0.60×
2.75×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RXO
RXO
SEM
SEM
Operating Cash FlowLast quarter
$7.0M
$64.3M
Free Cash FlowOCF − Capex
$-9.0M
$5.2M
FCF MarginFCF / Revenue
-0.6%
0.4%
Capex IntensityCapex / Revenue
1.1%
4.2%
Cash ConversionOCF / Net Profit
3.19×
TTM Free Cash FlowTrailing 4 quarters
$-8.0M
$117.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RXO
RXO
SEM
SEM
Q4 25
$7.0M
$64.3M
Q3 25
$23.0M
$175.3M
Q2 25
$23.0M
$110.3M
Q1 25
$-2.0M
$-3.5M
Q4 24
$-7.0M
$125.4M
Q3 24
$-7.0M
$181.0M
Q2 24
$-5.0M
$278.2M
Q1 24
$7.0M
$-66.7M
Free Cash Flow
RXO
RXO
SEM
SEM
Q4 25
$-9.0M
$5.2M
Q3 25
$9.0M
$122.2M
Q2 25
$9.0M
$45.6M
Q1 25
$-17.0M
$-55.8M
Q4 24
$-19.0M
$62.0M
Q3 24
$-18.0M
$130.3M
Q2 24
$-16.0M
$222.6M
Q1 24
$-4.0M
$-119.2M
FCF Margin
RXO
RXO
SEM
SEM
Q4 25
-0.6%
0.4%
Q3 25
0.6%
9.0%
Q2 25
0.6%
3.4%
Q1 25
-1.2%
-4.1%
Q4 24
-1.1%
4.7%
Q3 24
-1.7%
10.2%
Q2 24
-1.7%
17.4%
Q1 24
-0.4%
-9.0%
Capex Intensity
RXO
RXO
SEM
SEM
Q4 25
1.1%
4.2%
Q3 25
1.0%
3.9%
Q2 25
1.0%
4.8%
Q1 25
1.0%
3.9%
Q4 24
0.7%
4.8%
Q3 24
1.1%
4.0%
Q2 24
1.2%
4.3%
Q1 24
1.2%
4.0%
Cash Conversion
RXO
RXO
SEM
SEM
Q4 25
3.19×
Q3 25
6.09×
Q2 25
2.72×
Q1 25
-0.06×
Q4 24
Q3 24
3.25×
Q2 24
3.59×
Q1 24
-0.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RXO
RXO

Retail Sector$546.0M37%
Last Mile$298.0M20%
Food And Beverage Sector$225.0M15%
Other Sector$185.0M13%
Managed Transportation$133.0M9%
Automotive Sector$93.0M6%

SEM
SEM

Critical Illness Recovery Hospitals$629.7M45%
Health Care Patient Service Non Medicare$428.6M31%
Rehabilitation Hospitals$339.2M24%

Related Comparisons